News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Balance sheet
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Euroseas reported a net income of $33.2 million in Q2 2026, driven by strong containership charter rates and low drydocking expenses, making it one of the company's most profitable quarters in 15 years. The company has expanded its newbuilding program to 12 feeder and …
Euroseas Ltd. reported strong financial results for Q2 2026, including a net profit of $32.6 million and an increase in Adjusted basic EPS to $9.45 for the first half of the year. The company declared a quarterly dividend of $0.80 per share and highlighted …
Key Points Interested in Euroseas Ltd.? Here are five stocks we like better. Strong second-quarter results: Euroseas reported $33.2 million in net income and $40.1 million in adjusted EBITDA, while its average time-charter-equivalent rate increased to $30,306 per vessel per day despite operating one …
Euroseas Ltd. reported strong second-quarter 2026 results, surpassing profit estimates with adjusted earnings of $4.70 per share, significantly above the $4.09 forecast. The company's performance was driven by robust charter rates, near-perfect fleet utilization, and reduced financing costs, despite a slight revenue miss. Euroseas …
Euroseas Ltd. (ESEA) reported strong Q2 2026 earnings, surpassing Zacks Consensus Estimates for both earnings per share ($4.7 vs. $4.47 expected) and revenues ($58.08 million vs. $57.99 million expected). The company's shares have risen 36.4% year-to-date, outperforming the S&P 500. Investors are now looking …
Euroseas Ltd. announced strong financial results for the second quarter and first half of 2026, with significant net revenues and earnings per share, driven by high charter rates and low drydocking expenses. The company also declared a quarterly dividend of $0.80 per share and …
Euroseas Ltd. has announced that it will release its financial results for the second quarter ended June 30, 2026, on Monday, August 25, 2026. The company will also host a conference call and webcast on the same day to discuss the results. This event …
Matthew B. Gorson, a director at Millrose Properties, Inc. (MRP), recently purchased 3,000 shares of the company’s Class A Common Stock for $86,400, increasing his total holdings to 38,750 shares. This insider transaction follows Millrose Properties' strong second-quarter earnings, where revenue exceeded expectations and …
Carlos A. Migoya, a director at Millrose Properties Inc. (NASDAQ:MRP), recently purchased 1,000 shares of the company's Class A Common Stock for $29.18 per share, totaling $29,180. This transaction increases his direct beneficial ownership to 30,075 shares, with the stock currently trading near his …
Carlos A. Migoya, a director of Millrose Properties, Inc. (MRP), purchased 1,000 shares of Class A Common Stock on August 7, 2026, at $29.18 per share in an open market transaction. This transaction increased his direct holdings to 30,075 shares. The filing, a Form …
Euroseas Ltd. (ESEA) will release its second-quarter 2026 financial results on August 13, 2026, before market open, followed by a conference call at 9:00 am ET. The company, an owner and operator of container carrier vessels, currently manages a 21-vessel fleet with plans to …
Euroseas (NASDAQ: ESEA) is scheduled to release its second-quarter 2026 financial results on August 13, 2026, before the U.S. market opens. Management will host a conference call and live webcast on the same day at 9:00 a.m. Eastern Time to discuss the results. The …
This article provides an AI-generated analysis for Euroseas Ltd. (NASDAQ: ESEA), highlighting weak near-term sentiment with a potential shift in mid and long-term outlook. It details specific trading strategies for different risk profiles, including a short setup with an exceptional 35.3:1 risk-reward ratio, and …
This article provides current stock information for Euroseas Ltd (ESEA), including its latest closing price, after-hours trading, market capitalization, and P/E ratio. It highlights that more news for ESEA is expected soon. The page serves as a hub for financial data and news updates …
Euroseas Ltd (ESEA) is expected to announce earnings of $4.24 per share. This financial projection is based on a Refinitiv report. The article serves as an earnings preview for the company.
Millrose Properties Inc. has amended its credit agreement, resulting in a 0.25 percentage point reduction in the annual interest rate on its loans. This move is expected to lower financing costs, improve cash flow, and strengthen the company's balance sheet. Analysts currently rate MRP …
Transaction marks a meaningful expansion of Millrose's role as the premier strategic capital partner for homebuilder mergers and acquisitions MIAMI, August 07, 2026--(BUSINESS WIRE)--Millrose Properties, Inc. (NYSE: MRP, "Millrose"), the homesite option platform for residential homebuilders, today announced a commitment by its manager to …
Euroseas Ltd (ESEA) has an earnings forecast score of 8.00, ranking 14th in the Freight & Logistics Services industry. Analysts have set an average price target of $75.00, with most recommending a "Buy" rating. The company's expected revenue for the next quarter is $56.10M, …
Millrose Properties Inc Class A (MRP) has released its Q1 2025 earnings report. The company reported actual EPS of $0.39, exceeding its previous year's EPS of -$0.34, but missed revenue expectations by $21.34 million with an actual revenue of $82.70 million against an expected …
NeuroSense Therapeutics (NASDAQ: NRSN) has successfully completed the Pre-NDS process with Health Canada for PrimeC, its lead ALS therapeutic candidate. The company aims to file a New Drug Submission (NDS) in December 2026, with Health Canada indicating no concerns with the proposed timeline and …
NeuroSense Therapeutics announced it has completed the Pre-NDS process with Health Canada for PrimeC, its lead therapeutic candidate for ALS, and is targeting a New Drug Submission (NDS) filing in December 2026. This follows alignment with Health Canada on the submission's content and structure. …
Search by ticker symbol or company name and select a result to open its chart.